WASHINGTON — After 15 years at the helm of the lobbying group for pharmacy benefit managers, Mark Merritt’s parting gift was a stone blue baseball cap. “PCMA,” the group’s acronym, was embroidered in red on the front, “Merritt 15-0” in white on the back.

“15 years here and we haven’t had any significant losses,” explained Merritt, the group’s current CEO.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Of course he has “No regrets” because he knows that the criminals that helped him fleece the American taxpayers, won’t be indicted. He know he is above the Law. Our federal regulators were unable to turn down the money this guy generated for his Industry. He was incredibly effective handling how the media covered, or didn’t the billions of extra dollars these criminals added to the Medicare Part D program. Just another corporate criminal normalized by industry funded media outlets like this one.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy